Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A

Virginia L. Pulito, Victoria A. Roberts, John R. Adair, Annette L. Rothermel, Alexander M. Collins, Sally S. Varga, Cathy Martocello, Mark Bodmer, Linda K. Jolliffe, Robert A. Zivin

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

OKT4A, a murine mAb that recognizes an epitope on the CD4 receptor, is a potent immunosuppressive agent in vitro and in a variety of nonhuman primate models of graft rejection and autoimmune disease. Initial human cardiac transplant trials suggest that OKT4A does not cause either cytokine release syndrome or CD4+ cell depletion, but does induce a human anti-mouse Ab (HAMA) response despite strong concurrent immunosuppression. To further investigate the potential of OKT4A as an immunomodulator, it was necessary to decrease its immunogenicity. Therefore, we developed a humanized version of this Ab (gOKT4A-4), which has the same binding affinity and in vitro immunosuppressive properties of OKT4A, but retains only three murine sequence-derived amino acid residues outside of the complementarity-determining regions (CDRs). Detailed computer modeling of both OKT4A and gOKT4A-4 provided a computational rationale for the changes necessary to regain activity after humanization. This has also provided a plausible representation of the Ag binding site. Preliminary clinical results with gOKT4A-4 suggest that we have eliminated the immunogenicity observed in the parent murine Ab.

Original languageEnglish
Pages (from-to)2840-2850
Number of pages11
JournalJournal of Immunology
Volume156
Issue number8
StatePublished - Apr 15 1996

Fingerprint

Immunosuppressive Agents
Complementarity Determining Regions
CD4 Antigens
Graft Rejection
Immunologic Factors
Immunosuppression
Primates
Autoimmune Diseases
Epitopes
Amino Acid Sequence
Binding Sites
OKT4A monoclonal antibody
Cytokines
Transplants
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology

Cite this

Pulito, V. L., Roberts, V. A., Adair, J. R., Rothermel, A. L., Collins, A. M., Varga, S. S., ... Zivin, R. A. (1996). Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A. Journal of Immunology, 156(8), 2840-2850.

Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A. / Pulito, Virginia L.; Roberts, Victoria A.; Adair, John R.; Rothermel, Annette L.; Collins, Alexander M.; Varga, Sally S.; Martocello, Cathy; Bodmer, Mark; Jolliffe, Linda K.; Zivin, Robert A.

In: Journal of Immunology, Vol. 156, No. 8, 15.04.1996, p. 2840-2850.

Research output: Contribution to journalArticle

Pulito, VL, Roberts, VA, Adair, JR, Rothermel, AL, Collins, AM, Varga, SS, Martocello, C, Bodmer, M, Jolliffe, LK & Zivin, RA 1996, 'Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A', Journal of Immunology, vol. 156, no. 8, pp. 2840-2850.
Pulito VL, Roberts VA, Adair JR, Rothermel AL, Collins AM, Varga SS et al. Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A. Journal of Immunology. 1996 Apr 15;156(8):2840-2850.
Pulito, Virginia L. ; Roberts, Victoria A. ; Adair, John R. ; Rothermel, Annette L. ; Collins, Alexander M. ; Varga, Sally S. ; Martocello, Cathy ; Bodmer, Mark ; Jolliffe, Linda K. ; Zivin, Robert A. / Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A. In: Journal of Immunology. 1996 ; Vol. 156, No. 8. pp. 2840-2850.
@article{982577a447d445cf95828b7664d9837b,
title = "Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A",
abstract = "OKT4A, a murine mAb that recognizes an epitope on the CD4 receptor, is a potent immunosuppressive agent in vitro and in a variety of nonhuman primate models of graft rejection and autoimmune disease. Initial human cardiac transplant trials suggest that OKT4A does not cause either cytokine release syndrome or CD4+ cell depletion, but does induce a human anti-mouse Ab (HAMA) response despite strong concurrent immunosuppression. To further investigate the potential of OKT4A as an immunomodulator, it was necessary to decrease its immunogenicity. Therefore, we developed a humanized version of this Ab (gOKT4A-4), which has the same binding affinity and in vitro immunosuppressive properties of OKT4A, but retains only three murine sequence-derived amino acid residues outside of the complementarity-determining regions (CDRs). Detailed computer modeling of both OKT4A and gOKT4A-4 provided a computational rationale for the changes necessary to regain activity after humanization. This has also provided a plausible representation of the Ag binding site. Preliminary clinical results with gOKT4A-4 suggest that we have eliminated the immunogenicity observed in the parent murine Ab.",
author = "Pulito, {Virginia L.} and Roberts, {Victoria A.} and Adair, {John R.} and Rothermel, {Annette L.} and Collins, {Alexander M.} and Varga, {Sally S.} and Cathy Martocello and Mark Bodmer and Jolliffe, {Linda K.} and Zivin, {Robert A.}",
year = "1996",
month = "4",
day = "15",
language = "English",
volume = "156",
pages = "2840--2850",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A

AU - Pulito, Virginia L.

AU - Roberts, Victoria A.

AU - Adair, John R.

AU - Rothermel, Annette L.

AU - Collins, Alexander M.

AU - Varga, Sally S.

AU - Martocello, Cathy

AU - Bodmer, Mark

AU - Jolliffe, Linda K.

AU - Zivin, Robert A.

PY - 1996/4/15

Y1 - 1996/4/15

N2 - OKT4A, a murine mAb that recognizes an epitope on the CD4 receptor, is a potent immunosuppressive agent in vitro and in a variety of nonhuman primate models of graft rejection and autoimmune disease. Initial human cardiac transplant trials suggest that OKT4A does not cause either cytokine release syndrome or CD4+ cell depletion, but does induce a human anti-mouse Ab (HAMA) response despite strong concurrent immunosuppression. To further investigate the potential of OKT4A as an immunomodulator, it was necessary to decrease its immunogenicity. Therefore, we developed a humanized version of this Ab (gOKT4A-4), which has the same binding affinity and in vitro immunosuppressive properties of OKT4A, but retains only three murine sequence-derived amino acid residues outside of the complementarity-determining regions (CDRs). Detailed computer modeling of both OKT4A and gOKT4A-4 provided a computational rationale for the changes necessary to regain activity after humanization. This has also provided a plausible representation of the Ag binding site. Preliminary clinical results with gOKT4A-4 suggest that we have eliminated the immunogenicity observed in the parent murine Ab.

AB - OKT4A, a murine mAb that recognizes an epitope on the CD4 receptor, is a potent immunosuppressive agent in vitro and in a variety of nonhuman primate models of graft rejection and autoimmune disease. Initial human cardiac transplant trials suggest that OKT4A does not cause either cytokine release syndrome or CD4+ cell depletion, but does induce a human anti-mouse Ab (HAMA) response despite strong concurrent immunosuppression. To further investigate the potential of OKT4A as an immunomodulator, it was necessary to decrease its immunogenicity. Therefore, we developed a humanized version of this Ab (gOKT4A-4), which has the same binding affinity and in vitro immunosuppressive properties of OKT4A, but retains only three murine sequence-derived amino acid residues outside of the complementarity-determining regions (CDRs). Detailed computer modeling of both OKT4A and gOKT4A-4 provided a computational rationale for the changes necessary to regain activity after humanization. This has also provided a plausible representation of the Ag binding site. Preliminary clinical results with gOKT4A-4 suggest that we have eliminated the immunogenicity observed in the parent murine Ab.

UR - http://www.scopus.com/inward/record.url?scp=0030584783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030584783&partnerID=8YFLogxK

M3 - Article

C2 - 8609403

AN - SCOPUS:0030584783

VL - 156

SP - 2840

EP - 2850

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -